Dihydropyrimidine Dehydrogenase Activity during Long-Term Adjuvant Treatment with Oral Uracil and Tegafur for Colorectal Cancer

Publisher： Karger

E-ISSN： 1421-9794|53|6|442-445

ISSN： 0009-3157

Source： Chemotherapy, Vol.53, Iss.6, 2007-10, pp. : 442-445

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Phase I Study of Oral Uracil-Tegafur Prior to Weekly Intravenous Gemcitabine in Patients with Advanced Pancreatic Cancer

By  

Chemotherapy, Vol. 52, Iss. 2, 2006-04 ,pp. : 98-102

Karger

Access to resources Recommend Favorite

Correlations of Clinicopathological Factors with Protein Expression Levels of Thymidylate Synthase, Dihydropyrimidine Dehydrogenase and Orotate Phosphoribosyltransferase in Colorectal Cancer

By  

Chemotherapy, Vol. 56, Iss. 2, 2010-04 ,pp. : 120-126

Karger

Access to resources Recommend Favorite

The Dihydrouracil/Uracil Ratios in Plasma and Toxicities of 5-Fluorouracil-Based Adjuvant Chemotherapy in Colorectal Cancer Patients

By  

Chemotherapy, Vol. 53, Iss. 2, 2007-02 ,pp. : 127-131

Karger

Access to resources Recommend Favorite

Long-Term Outcomes and Prognostic Factors of High-Risk Malignant Melanoma Patients after Surgery and Adjuvant High-Dose Interferon Treatment: A Single-Center Experience

By  

Chemotherapy, Vol. 60, Iss. 4, 2015-04 ,pp. : 228-238

Karger

Access to resources Recommend Favorite

Release of Terpenes from Fir Wood during Its Long-Term Use and in Thermal Treatment

By Kačík František   Veľková Veronika   Šmíra Pavel   Nasswettrová Andrea   Kačíková Danica   Reinprecht Ladislav  

Molecules, Vol. 17, Iss. 8, 2012-08 ,pp. : 9990-9999

MDPI

Access to resources Recommend Favorite